12:00 AM
 | 
May 05, 2003
 |  BioCentury  |  Finance

Restructuring watch

Restructuring watch

Date Company Staff cuts Notes Current Cash Years cash pre-cut 2002 Op loss Cash reporting date
4/28/2003 Aclara (ACLA) 32% to 65 Done to focus on commercializing its eTag assay system; eliminated some executive positions, as well as cuts in administration, marketing and basic research. $101.3 3.0 $33.6 3/31
4/3/2003

Read the full 427 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >